ONC Q3 2024 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q3 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$1.0B+28.2% YoY

Gross Profit

$831M83.0% margin

Operating Income

-$120M-12.0% margin

Net Income

-$121M-12.1% margin

EPS (Diluted)

$-1.16

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

$188M

Free Cash Flow

$55M

Stock-Based Comp.

$115M

Balance Sheet

Total Assets

$5.8B

Total Liabilities

$2.4B

Stockholders' Equity

$3.4B

Cash & Equivalents

$2.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$781M	+28.2%
Gross Profit	$831M	$685M	+21.3%
Operating Income	-$120M	-$134M	+10.2%
Net Income	-$121M	$215M	-156.3%